MAY 24, 2019 01:02 PM PDT

What do parasitic fish have to do with cancer?

Have you ever seen a lamprey up close? If you haven’t, you should probably count your blessings, because these fish are terrifying to look at. With their jawless, tooth-filled mouths, a lamprey, which is a parasitic fish that resembles and eel and feeds on the blood of other fish, is enough to induce nightmares in adult humans.

Yet new research published in Science Advances suggests that lampreys might be the perfect vehicle for drugs that treat brain tumors, cancer, and even stroke. The research comes from a team of scientists at the University of Wisconsin-Madison and the University of Texas at Austin and analyzes a type of molecule from the immune system of lampreys, called "variable lymphocyte receptors" (VLRs).

VLRs are unique in their capacity to reach the extracellular matrix or ECM (think back to high school biology class!). "Similar to water soaking into a sponge, the lamprey molecules will potentially accumulate much more of the drug in the abundant matrix around cells compared to specific delivery to cells," explained co-author Professor John Kuo.

Because ECM networks compose a significant part of the central nervous system, the researchers think that VLRs are capable of transporting drugs to the brain more effectively for treatments for brain conditions, particularly in scenarios where the brain-blood barrier has been affected.

(Quick side note: in case you haven’t heard of the brain-blood barrier, it is a physiological aspect that stops potentially harmful agents leaking into the brain but also, therefore does not allow drugs to easily penetrate the brain. In the case of some health situations where the brain is affected, the brain-blood barrier becomes more permeable, which can lead to other problems but on the flip side but also allows drugs to get in.)

"Molecules like this [VLRs] normally couldn't ferry cargo into the brain, but anywhere there's a blood-brain barrier disruption, they can deliver drugs right to the site of pathology," explains lead author Professor Eric Shusta.

A lamprey, in all its glory. Photo: Phys.org

The researchers conducted their investigations on mouse models of glioblastoma, an aggressive form of brain cancer. They found that mice that received treatment of VLRs bound to doxorubicin, a drug used to treat this cancer, resulted in prolonged survival of the individuals. While more research is needed on this topic, the investigators are hopeful about what their findings could mean for future treatment methods.

Sources: Medical News Today, Science Advances

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUN 20, 2019
Cancer
JUN 20, 2019
Can Chemotherapy Be Improved?
With all of these "new and improved" methods to treat cancer, such as immuno-based, using nanotechnology, to genetic-based personalized treatment...
JUN 20, 2019
Genetics & Genomics
JUN 20, 2019
Tracking the Activity of a Cancer Gene
MYC is a proto-oncogene, meaning it can contribute to the development of cancer when it carries mutations....
JUN 20, 2019
Cancer
JUN 20, 2019
Children with liver cancer may not need as much chemo
Results from a phase 3 clinical trial show that children with liver cancer may not need as much chemotherapy as has been traditionally administered. The mo...
JUN 20, 2019
Cancer
JUN 20, 2019
Common food additive could lead to colorectal cancer
Have you ever heard of E171? Otherwise known as titanium dioxide nanoparticles, E171 is a common additive in foods and medicines and is used as a whitening...
JUN 20, 2019
Cancer
JUN 20, 2019
Low-fat diets in women can reduce mortality rates of breast cancer
Results from an almost thirty-year clinical trial regarding women’s nutritional health and breast cancer were announced recently and will be presente...
JUN 20, 2019
Cancer
JUN 20, 2019
This Molecule Compound Reduces Chemo Resistance
Drug resistance is a major hindrance to cancer treatment. Researchers from Duke University, MIT and the University of Rhode Island have zeroed in on a mole...
Loading Comments...